BCL2 and acute myeloid leukemia: The anti-apoptotic protein B-cell lymphoma 2 (BCL-2) is highly expressed in leukemia stem cells and is linked to chemotherapy resistance and poor prognosis in acute myeloid leukemia patients (12, 13).